Prism Medico and Pharmacy Limited held an e-EGM on March 20, 2026 to vote on two special resolutions.
Both resolutions — alteration of Clause 15 of AoA and preferential issue of equity shares and convertible warrants — passed with 99.98% votes in favour.
Scrutinizer's Report filed with BSE and MSEIL on March 24, 2026 pursuant to Section 108 of Companies Act, 2013 and SEBI LODR Regulation 44.